Holen Sie sich die Stockscreener-App
49.11
3.04%
1.45
Schlusskurs vom Vortag:
$47.66
Offen:
$47.62
24-Stunden-Volumen:
1.06M
Relative Volume:
0.71
Marktkapitalisierung:
$3.01B
Einnahmen:
$362.27M
Nettoeinkommen (Verlust:
$-85.19M
KGV:
-33.87
EPS:
-1.45
Netto-Cashflow:
$-68.71M
1W Leistung:
-0.26%
1M Leistung:
+22.10%
6M Leistung:
+71.41%
1J Leistung:
+4.78%
1-Tages-Spanne:
$47.62
$50.17
1-Wochen-Bereich:
$46.17
$50.65
52-Wochen-Spanne:
$23.30
$51.00
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
49.11 | 2.92B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Eingeleitet | Stephens | Overweight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Insider Sell: Adam Laponis Sells 7,000 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience (NASDAQ:TWST) Insider Dennis Cho Sells 5,000 Shares - MarketBeat
Twist Bioscience Corporation (NASDAQ:TWST) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes - Yahoo Finance
Twist Bioscience (NASDAQ:TWST) Director Sells $105,402.00 in Stock - MarketBeat
Twist Bioscience shareholders approve director elections and executive compensation - Investing.com
Twist Bioscience shareholders approve director elections and executive compensation By Investing.com - Investing.com Australia
Twist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 5,001 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) CAO Robert Werner Sells 7,000 Shares - MarketBeat
Twist Bioscience (TWST) Valuation After Q1 Beat And Raised 2026 Outlook - simplywall.st
Commit To Purchase Twist Bioscience At $37.50, Earn 27.6% Annualized Using Options - Nasdaq
Twist Bioscience Guidance Lift Puts AI Demand And Risks In Focus - Yahoo Finance
Assessing Twist Bioscience (TWST) Valuation After Recent Share Price Momentum - Yahoo Finance
Decoding Twist Bioscience Corp (TWST): A Strategic SWOT Insight - GuruFocus
6 Analysts Assess Twist Bioscience: What You Need To Know - Benzinga
TWST: Evercore ISI Group Raises Price Target on Twist Bioscience - GuruFocus
Barclays Raises Price Target for Twist Bioscience (TWST) to $50 - GuruFocus
These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results - Benzinga
Twist Bioscience Corporation $TWST Stake Raised by Thrivent Financial for Lutherans - MarketBeat
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript - Insider Monkey
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - ChartMill
Twist Bioscience Corporation (TWST): A Bull Case Theory - Finviz
Twist Bioscience Corp SEC 10-Q Report - TradingView
Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Twist Bioscience Q1 2026 slides: Revenue beats guidance, path to profitability accelerates By Investing.com - Investing.com South Africa
Why Is Twist Bioscience Stock Soaring Monday? - Benzinga
Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: S - GuruFocus
Twist Bioscience (NASDAQ:TWST) Shares Gap UpStill a Buy? - MarketBeat
Twist Bioscience (TWST) Stock Surges Over 12% - GuruFocus
Twist Bioscience stock jumps as record quarterly revenue lifts 2026 outlook — what investors watch next - TechStock²
Twist Bioscience (TWST) Boosts Revenue Forecast, Shares Rise - GuruFocus
Twist Bioscience earnings missed by $0.07, revenue topped estimates - Investing.com Canada
Earnings call transcript: Twist Bioscience Q1 2026 sees revenue growth, stock surges - Investing.com India
Twist Bioscience Stock Climbs 7% Over Narrower Loss In Q1 - Nasdaq
Twist Bioscience Q1 2026 Earnings Call Transcript - MarketBeat
Twist Bioscience (TWST) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
TWIST BIOSCIENCE CORP (NASDAQ:TWST) Reports Mixed Q1 FY2026 Results with Revenue Beat and Wider Loss - ChartMill
Twist Bioscience (TWST) Surpasses Revenue Expectations in Q1 - GuruFocus
Twist Bioscience (TWST) Reports Q1 Revenue Beat, EPS Miss - GuruFocus
TWST Reports Impressive Revenue Growth in Latest Financial Update - GuruFocus
Twist Bioscience: Fiscal Q1 Earnings Snapshot - KVUE
Twist Bioscience (TWST) Raises Revenue Forecast for 2026 - GuruFocus
Twist Bioscience Q1 Earnings Report: What Investors Need to Know - Benzinga
Twist Bioscience stock rises 5% on revenue beat, raised guidance - Investing.com
Twist Bioscience Earnings Report: Q1 Overview - Benzinga
Twist Bioscience Corporation $TWST Shares Purchased by New York State Common Retirement Fund - MarketBeat
Twist Bioscience: Overview of First Fiscal Quarter Results - Bitget
Earnings Summary: Twist Bioscience Q1 - Benzinga
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results - Business Wire
Earnings Outlook For Twist Bioscience - Benzinga
Momentum Shift: Can Twist Bioscience Corporation deliver consistent EPS growthPortfolio Performance Report & High Accuracy Investment Signals - baoquankhu1.vn
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):